Published in Int J Tryptophan Res on July 21, 2013
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model. Mol Autism (2015) 0.87
A fully integrated new paradigm for lithium's mode of action - lithium utilizes latent cellular fail-safe mechanisms. Neuropsychiatr Dis Treat (2017) 0.75
Measurement of Serum Superoxide Dismutase and Its Relevance to Disease Intensity Autistic Children. Maedica (Buchar) (2015) 0.75
Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale. Int J Tryptophan Res (2017) 0.75
Tryptophan status in autism spectrum disorder and the influence of supplementation on its level. Metab Brain Dis (2017) 0.75
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord (2000) 37.47
G proteins: transducers of receptor-generated signals. Annu Rev Biochem (1987) 27.41
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab (2001) 11.01
Prevalence of autism in a US metropolitan area. JAMA (2003) 10.37
Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 9.23
Adiponectin and adiponectin receptors. Endocr Rev (2005) 8.46
Identification and evaluation of children with autism spectrum disorders. Pediatrics (2007) 7.54
Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med (2000) 6.25
Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95
Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry (2011) 5.85
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet (2004) 5.15
Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab (2001) 5.06
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ (2007) 4.70
Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature (2003) 4.27
A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron (2005) 3.93
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 3.90
NAD+ metabolism in health and disease. Trends Biochem Sci (2006) 3.45
Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol (2005) 3.36
Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res (2008) 3.12
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr (2004) 3.00
Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron (2006) 2.98
Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr (2005) 2.98
Epilepsy in autism. Lancet Neurol (2002) 2.93
The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry (1989) 2.85
Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry (2005) 2.78
Immune proteins in brain development and synaptic plasticity. Neuron (2009) 2.72
Oxidative stress and apoptosis. Pathophysiology (2000) 2.58
The biochemistry of memory: a new and specific hypothesis. Science (1984) 2.52
Motor coordination in autism spectrum disorders: a synthesis and meta-analysis. J Autism Dev Disord (2010) 2.51
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol (2008) 2.44
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet (2006) 2.44
Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol (2005) 2.39
Mitochondrial disorders. Brain (2004) 2.32
The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun (2011) 2.24
Mitochondrial dysfunction in autism. JAMA (2010) 2.04
Oxidative stress and Alzheimer disease. Am J Clin Nutr (2000) 2.01
The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life (2002) 1.99
Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord (2001) 1.99
Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron (1990) 1.93
Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol (1999) 1.90
Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J (2009) 1.89
Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol (2005) 1.85
Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol (2001) 1.85
Prevalence of motor impairment in autism spectrum disorders. Brain Dev (2007) 1.80
Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol (2009) 1.78
Maternal infection and immune involvement in autism. Trends Mol Med (2011) 1.78
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res (2008) 1.73
Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol (2005) 1.70
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68
Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science (2012) 1.63
How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology (2007) 1.63
Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) (2011) 1.58
Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics (2003) 1.56
Energy metabolism in mammalian brain during development. Prog Neurobiol (2004) 1.54
Clinical assessment of autism in high-risk 18-month-olds. Autism (2008) 1.54
Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol (2006) 1.53
Oxidative stress in autism. Altern Ther Health Med (2004) 1.52
Stability of motor problems in young children with or at risk of autism spectrum disorders, ADHD, and or developmental coordination disorder. Dev Med Child Neurol (2010) 1.52
Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr (2004) 1.49
The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology (2001) 1.46
The relation between general cognitive level and adaptive behavior domains in individuals with autism with and without co-morbid mental retardation. Child Psychiatry Hum Dev (2002) 1.44
Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci (2004) 1.44
The NADH-ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are associated with autism. Acta Psychiatr Scand (2010) 1.43
Neuroscience. Autism's cause may reside in abnormalities at the synapse. Science (2007) 1.41
Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol (2000) 1.41
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology (2002) 1.40
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol (2002) 1.39
Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem (2006) 1.37
The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect (2000) 1.37
Intestinal pathophysiology in autism. Exp Biol Med (Maywood) (2003) 1.34
The neuropathology of autism: a review. J Neuropathol Exp Neurol (2005) 1.34
Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids (2005) 1.34
Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech (2010) 1.33
Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem (2009) 1.30
Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol (2003) 1.30
IDO expression in the brain: a double-edged sword. J Mol Med (Berl) (2007) 1.30
L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res (2009) 1.29
Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol (2007) 1.29
Analyses of toxic metals and essential minerals in the hair of Arizona children with autism and associated conditions, and their mothers. Biol Trace Elem Res (2006) 1.28
Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta (2009) 1.25
Plasma amino acid levels in children with autism and their families. J Autism Dev Disord (2003) 1.24
Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem (2011) 1.24
Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol (2008) 1.23
Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem (1987) 1.22
Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A (2007) 1.22
Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.22
Adipokines and the blood-brain barrier. Peptides (2007) 1.22
Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta (1998) 1.21
Mercury and autism: accelerating evidence? Neuro Endocrinol Lett (2005) 1.21
Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur J Pharmacol (2011) 1.21
Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci (2004) 1.21
Pyridine nucleotides and rate control. Symp Soc Exp Biol (1973) 1.20
A simplified model for mitochondrial ATP production. J Theor Biol (2006) 1.19
A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res (2008) 1.18
Relative carnitine deficiency in autism. J Autism Dev Disord (2004) 1.18
Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta (2003) 1.16
Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids (2002) 1.13
The protective action of superoxide dismutase on metal-ion catalysed peroxidation of phospholipids. Biochem Biophys Res Commun (1977) 1.12
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature (2011) 4.63
Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition (2013) 2.13
Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res (2009) 2.01
Biomedical publications profile and trends in gulf cooperation council countries. Sultan Qaboos Univ Med J (2012) 1.87
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One (2011) 1.81
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation (2011) 1.56
Characterization of the kynurenine pathway in human neurons. J Neurosci (2007) 1.44
Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology (2012) 1.31
Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport (2006) 1.26
Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One (2012) 1.23
The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One (2009) 1.15
Prevalence and age-of-onset distributions of DSM IV mental disorders and their severity among school going Omani adolescents and youths: WMH-CIDI findings. Child Adolesc Psychiatry Ment Health (2009) 1.11
Variation in socio-economic burden for caring of children with autism spectrum disorder in Oman: caregiver perspectives. J Autism Dev Disord (2013) 1.11
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem (2006) 1.08
Characterisation of the expression of NMDA receptors in human astrocytes. PLoS One (2010) 1.08
Effects of Kynurenine Pathway Metabolites on Intracellular NAD Synthesis and Cell Death in Human Primary Astrocytes and Neurons. Int J Tryptophan Res (2009) 1.07
Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res (2012) 1.07
Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res (2009) 1.07
Is Alzheimer's a disease of the white matter? Curr Opin Psychiatry (2013) 1.05
Impact of geographical proximity on health care seeking behaviour in northern oman. Sultan Qaboos Univ Med J (2008) 1.04
Activated actin-depolymerizing factor/cofilin sequesters phosphorylated microtubule-associated protein during the assembly of alzheimer-like neuritic cytoskeletal striations. J Neurosci (2009) 1.03
The kynurenine pathway in brain tumor pathogenesis. Cancer Res (2012) 1.03
Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. FEBS J (2011) 1.02
Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol (2012) 1.01
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J Neuroinflammation (2009) 1.00
Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J (2009) 1.00
Emerging Burden of Frail Young and Elderly Persons in Oman: For whom the bell tolls? Sultan Qaboos Univ Med J (2012) 1.00
Silent Epidemic of Depression in Women in the Middle East and North Africa Region: Emerging tribulation or fallacy? Sultan Qaboos Univ Med J (2009) 1.00
p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J Neurooncol (2012) 1.00
Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm (Vienna) (2011) 0.99
Hikikomori, is it a culture-reactive or culture-bound syndrome? Nidotherapy and a clinical vignette from Oman. Int J Psychiatry Med (2005) 0.97
Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility. J Microencapsul (2011) 0.97
M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. PLoS One (2012) 0.96
Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutr Neurosci (2014) 0.94
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLoS One (2013) 0.93
Tendency toward deliberate food restriction, fear of fatness and somatic attribution in cross-cultural samples. Eat Behav (2007) 0.92
Enemy within?: The silent epidemic of substance dependency in GCC countries. J Sci Res Med Sci (2002) 0.92
Types and sociodemographic correlates of complementary and alternative medicine (CAM) use among people with epilepsy in Oman. Epilepsy Behav (2013) 0.92
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res (2013) 0.92
Hyperactivity in a sample of Omani schoolboys. J Atten Disord (2008) 0.91
Levels of heavy metals and essential minerals in hair samples of children with autism in Oman: a case-control study. Biol Trace Elem Res (2012) 0.91
Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J Alzheimers Dis (2009) 0.91
Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease. J Neurochem (2009) 0.90
Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxid Med Cell Longev (2013) 0.90
Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longev (2013) 0.90
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.89
Novel mutation of GLRA1 in Omani families with hyperekplexia and mild mental retardation. Pediatr Neurol (2012) 0.89
Deliberate self-poisoning in Oman. Trop Med Int Health (2002) 0.89
Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages. Fundam Clin Pharmacol (2009) 0.89
Signaling pathway cross talk in Alzheimer's disease. Cell Commun Signal (2014) 0.89
Economic growth, motorization, and road traffic injuries in the Sultanate of Oman, 1985-2009. Traffic Inj Prev (2013) 0.88
Increased markers of oxidative stress in autistic children of the Sultanate of Oman. Biol Trace Elem Res (2011) 0.88
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res (2009) 0.88
Mapping NAD(+) metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence. Biogerontology (2013) 0.88
Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons. Int J Tryptophan Res (2011) 0.87
Lead dysregulates serine/threonine protein phosphatases in human neurons. Neurochem Res (2010) 0.86
Association between body mass index and functional independence measure in patients with deconditioning. Am J Phys Med Rehabil (2008) 0.86
NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep (2012) 0.86
Role of Sirt1 during the ageing process: relevance to protection of synapses in the brain. Mol Neurobiol (2014) 0.85
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes. PLoS One (2013) 0.85
Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease. Neurochem Res (2015) 0.85
Understanding the roles of the kynurenine pathway in multiple sclerosis progression. Int J Tryptophan Res (2010) 0.85
Role of Rho/ROCK signaling in the interaction of melanoma cells with the blood-brain barrier. Pigment Cell Melanoma Res (2013) 0.85
Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors. Cent Nerv Syst Agents Med Chem (2009) 0.84
Clinical and Demographic Profile of Attendees at Baghdad's Walk-in Psychiatric Clinic. Oman Med J (2013) 0.84
Pilot study on the prevalence of abuse and mistreatment during clinical internship: a cross-sectional study among first year residents in Oman. BMJ Open (2013) 0.83
Gliotoxicity of the cyanotoxin, β-methyl-amino-L-alanine (BMAA). Sci Rep (2013) 0.83
The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes. Trends Parasitol (2012) 0.83
Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons. Toxicon (2012) 0.82
Relatives' advice and health care-seeking behaviour in oman. Sultan Qaboos Univ Med J (2009) 0.82
The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis. Stem Cells (2015) 0.82
Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis. J Neurochem (2011) 0.82
Ramadan fasting triggering koro-like symptoms during acute alcohol withdrawal: a case report from Oman. Transcult Psychiatry (2008) 0.82
The kynurenine pathway in stem cell biology. Int J Tryptophan Res (2013) 0.81
Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegener (2013) 0.81
Phenomenology and outcome of factitious disorders in otolaryngology clinic in Oman. Int J Psychiatry Med (2007) 0.81
A study on knowledge, attitude, and practice towards premarital carrier screening among adults attending primary healthcare centers in a region in Oman. BMC Public Health (2014) 0.81
Mangiferin antagonizes rotenone: induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells. Neurochem Res (2014) 0.80
Functional outcomes following anoxic brain injury: a comparison with traumatic brain injury. Brain Inj (2004) 0.80
'Flying coffins' and neglected neuropsychiatric syndromes in oman. Sultan Qaboos Univ Med J (2007) 0.80